Mannkind (MNKD) Assets (2010 - 2026)
Mannkind (MNKD) posted quarterly Assets of $744.4 million for Q1 2026, up 81.5% year-over-year from $410.1 million in Q1 2025, and down 6.03% quarter-over-quarter from $792.2 million in Q4 2025.
Mannkind (MNKD) Assets (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has reported Assets for 17 consecutive years, with $744.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets rose 81.5% year-over-year to $744.4 million; the TTM figure through Mar 2026 stood at $744.4 million (up 81.5% YoY), while the FY2025 annual figure was $792.2 million, up 101.14% from the prior year.
- Assets retreated to $744.4 million in Q1 2026 per MNKD's latest filing, from $792.2 million in the prior quarter.
- Across five years, Assets topped out at $792.2 million in Q4 2025 and bottomed at $285.8 million in Q2 2022.
- Historically, Assets has averaged $425.1 million across 5 years, with a median of $410.1 million in 2025.
- Annual changes were most pronounced in 2024 — Assets retreated 17.12% — and 2025, when it soared 101.14%.
- Mannkind's Assets stood at $295.3 million in 2022, then soared by 60.93% to $475.2 million in 2023, then fell by 17.12% to $393.8 million in 2024, then jumped by 101.14% to $792.2 million in 2025, then fell by 6.03% to $744.4 million in 2026.
- Business Quant data shows MNKD's Assets at $744.4 million in Q1 2026, $792.2 million in Q4 2025, and $494.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Mannkind | 1.19 Bn | 1.08 Bn | 94.97 Mn | 732.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 732.30 Mn |
| Mar 31, 2026 | 744.40 Mn |
| Dec 31, 2025 | 792.18 Mn |
| Sep 30, 2025 | 494.64 Mn |
| Jun 30, 2025 | 411.70 Mn |
| Mar 31, 2025 | 410.14 Mn |
| Dec 31, 2024 | 393.84 Mn |
| Sep 30, 2024 | 464.20 Mn |
| Jun 30, 2024 | 443.84 Mn |
| Mar 31, 2024 | 480.88 Mn |
| Dec 31, 2023 | 475.20 Mn |
| Sep 30, 2023 | 320.33 Mn |
| Jun 30, 2023 | 313.42 Mn |
| Mar 31, 2023 | 298.14 Mn |
| Dec 31, 2022 | 295.28 Mn |
| Sep 30, 2022 | 293.84 Mn |
| Jun 30, 2022 | 285.80 Mn |
| Mar 31, 2022 | 308.32 Mn |
| Dec 31, 2021 | 321.16 Mn |
| Sep 30, 2021 | 238.21 Mn |